Corbus Pharmaceuticals Holdings Inc. (CRBP) |
|
5.08 0.16 (3.25%)
|
12-12 16:00 |
|
Open: |
4.91 |
Pre. Close: |
4.92 |
|
High:
|
5.08 |
Low:
|
4.8944 |
|
Volume:
|
387,124 |
Market Cap:
|
329M |
|
|
|
|
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.966 - 4.987 |
4.987 - 5.006 |
|
Low:
|
4.77 - 4.792 |
4.792 - 4.814 |
|
Close:
|
4.884 - 4.919 |
4.919 - 4.952 |
|
Technical analysis |
as of: 2019-12-12 3:59:21 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 6.13 One year: 7.16 |
| Support: |
Support1: 4.59 Support2: 4.18 |
| Resistance: |
Resistance1: 5.25 Resistance2: 6.13 |
| Pivot: |
4.82 |
| Moving Average: |
MA(5): 4.98 MA(20): 4.72
MA(100): 5.18  MA(250): 6.32 |
| MACD: |
MACD(12,26): 0.05 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 65.61 %D(3): 65.27 |
| RSI: |
RSI(14): 57.68 |
| 52-week: |
High: 9.11 Low: 4.18 Change(%): -22.1 |
| Average Vol(K): |
3-Month: 59766 10-Days: 48560 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.CRBP has closed below upper band by 14.9%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-11-13
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) Crispr Therapeutics AG (NASDAQ: CRSP ) Diplomat Pharmacy Inc (NYSE: DPLO )( warned of going concern risk) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Galera Therapeutics Inc (NASDAQ: GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) XOMA Corp (NASDAQ: XOMA ) Zai Lab Ltd (NASDAQ: ZLAB ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov.
2019-11-12
Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
- Presentation with live audio webcast on Wednesday, November 20th at 5:20 PM DST - Norwood, MA , Nov. 12, 2019 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP).
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
64.67 |
| Shares Float (M) |
56.12 |
|
% Held by Insiders
|
5.45 |
|
% Held by Institutions
|
44.44 |
|
Shares Short (K)
|
16370 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
Book Value (p.s.)
|
0.460 |
|
PEG Ratio
|
|
|
Profit Margin
|
-175.17 |
|
Operating Margin
|
-190.17 |
|
Return on Assets (ttm)
|
-65.3 |
|
Return on Equity (ttm)
|
-171.5 |
|
Qtrly Rev. Growth
|
137.4 |
|
Gross Profit (p.s.)
|
-0.677 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.034 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-37.22 |
|
Levered Free Cash Flow (M)
|
-18.74 |
Stock Valuations |
|
P/E
|
-5.07 |
|
P/E Growth Ratio
|
0.03 |
|
P/BV
|
11.03 |
|
P/S
|
8.90 |
|
P/CF
|
-8.82 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
